The evaluation of an anti-HIV-1/-2 immunoassay demonstrated that the HIV-1 population's results were well separated from the cutoff using the method of estimating δ-values.

An immunoassay for HIV-1 reverse-transcriptase activity has been proposed as an alternative to nucleic acid testing for monitoring viral load for the purpose of patient management in resource-poor ...

The ABBOTT PRISM System is an automated immunoassay analyzer designed to perform Chemiluminescent immunoassay (ChLIA) technology. The ABBOTT PRISM performs batch/continuous access and STAT ...

With an intuitive operator interface, enhanced sample handling and innovative menu, the state-of-the-art Access 2 system delivers new levels of laboratory efficiency, standardization and cost ...

Metal organic gels (MOGs) as a new type of porous soft-hybrid supramolecular material have attracted widespread interest in various aspects due to their unique optical properties. In this work, we ...

ConspectusOver the past decade, experiments involving microdroplets have challenged the framework of chemistry. These droplets constitute a multiphase system, where the dynamic interplay between solid ...

Claudin-18 isoform 2 (CLDN18.2) has emerged as a promising therapeutic target in gastric or gastro-oesophageal junction cancer. Satricabtagene autoleucel (satri-cel; also known as CT041), an ...

In VOLTAIRE, a fully validated single-bridging electrochemiluminescence assay (ECLIA) following acid dissociation was used to measure the presence of ADAs and their titres.5 ECLIA is not only simpler ...

The bAbs against Spike were detected and quantified using a solid-phase electrochemiluminescence S-binding IgG immunoassay (ECLIA). This assay is validated and has been previously been described in ...